cate that microtubules play key functions in the control
of synaptic structure and function and that mutations times into the Drosophila genome. UAS transgenes were driven in tissue-specific patterns utilizing established perturbing microtubule dynamics are causatively linked with inherited neurological disorders.
GAL4 lines [26] including Tubulin-GAL4 (ubiquitous expression), Elav-GAL4 (nervous system-specific expresIt has recently been shown that Drosophila contains a highly conserved spastin homolog (Dspastin) [24] . The sion; presynaptic at the NMJ), and Myosin heavy chain (MHC)-GAL4 (muscle-specific expression; postsynaptic Drosophila NMJ system therefore provides an attractive opportunity to model HSP and to test the in vivo function at the NMJ) [25] . The efficacy of transgenic RNAi was assayed in two of D-Spastin. Here, we show that Drosophila Spastin is localized at the NMJ and specifically enriched in presynways: (1) RT-PCR of total mRNA harvested from animals expressing UAS-RNAi ubiquitously driven by the Tuaptic boutons. The dosage of Dspastin was altered in a targeted fashion in the nervous system with transgenic bulin-GAL4 driver, and (2) anti-D-Spastin immunocytochemistry on animals expressing UAS-RNAi in tissue-RNA interference (RNAi) [25] and overexpression techniques, and the consequence was assayed with elecspecific patterns, discussed below in greater detail.
Ubiquitous expression of the RNAi construct decreases trophysiology and confocal imaging. Knockdown of D-Spastin (i.e., reduction of Dspastin mRNA through
Dspastin mRNA levels as assayed by RT-PCR ( Figure  1A ). Amplification of Dspastin mRNA in all control lines RNAi) in neurons results in synaptic undergrowth. Conversely, loss of D-Spastin in neurons causes much results in a robust product of the expected size (2 kB), whereas UAS-RNAi; Tubulin-GAL4 individuals show no stronger neurotransmission, whereas D-Spastin overexpression weakens synaptic function. Microtubule stabildetectable Dspastin mRNA band, but only a product amplified from genomic DNA. This genomic fragment ity was assayed locally within the synapse by using antibodies specific to modified Tubulin, which label contamination persists when template RNA is pretreated with DNase I and also appears when reverse stable and long-lived microtubules. Knockdown of D-Spastin results in accumulation of stabilized Tubulin, transcriptase is omitted from the RT-PCR reaction mixture. These results indicate that the UAS-Dspastin-RNAi whereas D-Spastin overexpression conversely reduces stable microtubules. Direct pharmacological manipulatransgene effectively and specifically reduces Dspastin mRNA. tion of microtubule stability, to counter the observed defects, rescues the functional synaptic defects in both classes of Dspastin mutant. Together, these data pro-
Drosophila Spastin Protein Is Enriched vide the first in vivo evidence that Spastin regulates
at Synapses microtubule stability and show that this function of Spastin protein is highly enriched within the nervous Spastin strongly modulates both synaptic architecture system of mammals [27] . Recent work has shown that and neurotransmission strength.
the Dspastin message is similarly enriched in the nervous system during Drosophila embryonic development [24] . To determine the endogenous D-Spastin protein Results expression pattern at maturity and, in particular, to define the subcellular localization of D-Spastin protein in The Drosophila spastin Gene: Transgenic Manipulation of Expression neurons, we generated a polyclonal antibody against Drosophila Spastin. The specificity of this antibody was Human spastin is comprised of several functional domains, all of which are conserved in the Drosophila gene determined by Western blot analyses, which reveal a band of the predicted size for D-Spastin (84 kDa; data [24] . Overall, Dspastin exhibits 48% identity and 60% similarity at the amino acid level with the human homonot shown). We focused specifically on D-Spastin expression in the larval neuromusculature ( Figure 1B ) by log. Both human and Drosophila proteins contain a predicted transmembrane domain (40% identity), a microtuusing immunohistochemistry with the D-Spastin antiserum. bule interacting and organelle transport (MIT) domain (55% identity) and an ATPases associated with diverse D-Spastin protein is present in the cytoplasm of both neurons and muscles but is not detectably expressed cellular activities (AAA) domain (70% identity). The high degree of conservation of these motifs suggests that in nuclei ( Figure 1B) . While the protein is present at a low level throughout the neuromusculature, muscles, the function of Spastin has been tightly maintained throughout evolution.
and neuronal axons, D-Spastin is particularly enriched at NMJs throughout the body-wall muscles ( Figure 1C ). In order to alter D-Spastin expression in a targeted fashion within the nervous system, we constructed mulNMJs on the well-characterized four ventral longitudinal muscles (12, 13, 6 and 7) all exhibit similar levels of tiple, independent transgenic lines for both (1) the overexpression of the wild-type protein, and cally within presynaptic boutons ( Figure 1C Figure 1C The dosage level of D-Spastin appears to affect the synaptic efficacy sometimes appear to compensate for changes in synaptic area [29] and in other cases funcabundance and distribution of acetylated ␣-Tubulin within neurons. Neural-specific overexpression of D-Spastin tional strength parallels changes in synaptic area [30, 31] , and therefore the relationship between these pa-(Elav-GAL4; UAS-Dspastin) causes a reduction of acetylated ␣-Tubulin within neurons and specifically at NMJ rameters is variable. We employed a two-electrode voltage-clamp recording configuration to record synaptic presynaptic terminals ( Figure 3A ; middle row). After D-Spastin overexpression, bundled acetylated ␣-Tubucurrents at the NMJ in animals with altered D-Spastin expression specifically within the presynaptic terminal.
lin in axons appears thinned and shortened and, often, the stabilized Tubulin network is no longer detectable In normal animals, stimulation of the motor nerve with it a logical choice for modeling the neurological role of These data show that synaptic function can be rescued Spastin in vivo. We have used a targeted transgenic by pharmacologically restoring, as appropriate, the staapproach for RNAi knockdown and overexpression of bility of microtubules in animals with altered levels of Spastin in the nervous system to assay the in vivo reneuronal D-Spastin and further suggest that these quirement for Spastin specifically in neurons. Drosophila Spastin is widely expressed in many cell trangenic conditions cannot be enhanced pharmacolog- case is presently unclear.
